XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 82 filers reported holding XENON PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $718,100 | -12.7% | 21,500 | 0.0% | 0.15% | -18.7% |
| Q2 2023 | $822,375 | -3.0% | 21,500 | 0.0% | 0.18% | -43.3% |
| Q4 2022 | $847,745 | +9.0% | 21,500 | 0.0% | 0.32% | +68.1% |
| Q3 2022 | $778,000 | +3.2% | 21,500 | -12.2% | 0.19% | +15.8% |
| Q2 2022 | $754,000 | -2.2% | 24,500 | 0.0% | 0.16% | +24.1% |
| Q4 2021 | $771,000 | +0.1% | 24,500 | 0.0% | 0.13% | -5.0% |
| Q3 2021 | $770,000 | +69.2% | 24,500 | 0.0% | 0.14% | +59.1% |
| Q2 2021 | $455,000 | +5.3% | 24,500 | 0.0% | 0.09% | -3.3% |
| Q1 2021 | $432,000 | +15.5% | 24,500 | 0.0% | 0.09% | +7.1% |
| Q4 2020 | $374,000 | +29.9% | 24,500 | 0.0% | 0.08% | +9.0% |
| Q3 2020 | $288,000 | – | 24,500 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ghost Tree Capital, LLC | 790,000 | $12,071,000 | 3.53% |
| GREAT POINT PARTNERS LLC | 700,000 | $10,696,000 | 2.49% |
| COMMODORE CAPITAL LP | 579,432 | $8,854,000 | 2.33% |
| ACUTA CAPITAL PARTNERS, LLC | 417,409 | $6,378,000 | 2.25% |
| DAFNA Capital Management LLC | 406,535 | $6,212,000 | 1.65% |
| Tri Locum Partners LP | 264,134 | $4,036,000 | 1.60% |
| Parkman Healthcare Partners LLC | 311,207 | $4,755,000 | 1.20% |
| Ghost Tree Capital, LLC | 250,000 | $3,820,000 | 1.12% |
| Nan Fung Group Holdings Ltd | 197,880 | $3,024,000 | 0.97% |
| BVF INC/IL | 1,571,778 | $24,017,000 | 0.94% |